CENTA Price Prediction Next Week
Prediction and Recommendation for CENTA
Based on the analysis of news sentiment, technical indicators, and earnings performance, here is the prediction for CENTA's stock price for the next trading week:
Technical Analysis:
- Current Price: $31.595 (as of 2025-03-24)
- Fibonacci Levels:
- Pivot Point: $31.63
- Resistance Levels: $32.63 (R1), $33.25 (R2)
- Support Levels: $30.63 (S1), $30.01 (S2)
- MACD: Slightly negative, indicating bearish momentum.
- RSI: 46.52 (6-period), 47.32 (12-period), 47.56 (14-period), suggesting neutral momentum.
News Sentiment:
- Earnings Performance: CENTA reported quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share, marking an 800% earnings surprise compared to the previous year’s earnings of $0.01 per share.
- Zacks Rank: Currently ranked #3 (Hold), indicating expected performance in line with the market amid mixed estimate revisions for future earnings.
Price Prediction:
- Target Price: $33.25 (Fibonacci R2 level)
- Recommendation: Sell CENTA at $33.25 next week if the price reaches this resistance level, as it may face selling pressure.
Conclusion:
- CENTA is expected to reach $33.25 in the next trading week. Investors should consider selling at this level to lock in profits, as the stock may face resistance at this point.
CENTA Similar Chart Price Prediction
The price of CENTA is predicted to go up 9.57%, based on the high correlation periods with AUST. The similarity of these two price pattern on the periods is 90.23%.
CENTA
AUST
Up: 9.57%Similarity: 90.23%
CENTA Revenue Forecast
CENTA EPS Forecast
CENTA Analyst's Forecast
Andrea Faria
JP Morgan
Hold
2025-01-16
Price Target
$32 → $31
Upside
+0.58%
JPMorgan analyst Andrea Teixeira lowered the firm's price target on Central Garden & Pet to $31 from $32 and keeps a Neutral rating on the shares. The firm anticipates an "eventful earnings season" for the household and personal care group, with key debates into 2025 of consumption behavior, impact of currency, tariff risk for multinationals, financial expenses on higher rates for longer, and asset allocation. In light of the new U.S. administration and "many puts and takes" from a macro-political standpoint, JPMorgan expects companies will opt for a "very conservative approach to their outlook."
John Eade
Argus Research
Strong Buy → Hold
2025-01-07
Price Target
n/a
Downside
0%
Brian McNamara
Canaccord Genuity
Strong Buy
2024-11-26
Price Target
$48 → $45
Upside
+31.58%
